Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis.
paper
Cited
Public
Unavailable
- Authors
- Hunt, Glenn E; Malhi, Gin S; Cleary, Michelle; Lai, Harry Man Xiong; Sitharthan, Thiagarajan
- Year
- 2016
- Journal
- Journal of affective disorders
- PMID
- 27476137
- DOI
- 10.1016/j.jad.2016.07.011
BACKGROUND: Comorbidity between substance use disorders (SUDs) and bipolar disorder (BD) is highly prevalent to the extent it may almost be regarded the norm. This systematic review and meta-analysis aimed to estimate the prevalence rates of SUDs in treatment seeking patients diagnosed with BD in both inpatient and outpatient settings. METHODS: A comprehensive literature search of Medline, EMBASE, psychINFO and CINAHL databases was conducted from 1990 to 2015. Prevalence of co-morbid SUDs and BD were extracted and odds ratios (ORs) were calculated using random effects meta-analysis. RESULTS: There were 151 articles identified by electronic searches that yielded 22 large, multi-site studies and 56 individual studies describing comorbid rates of SUDs amongst community dwelling, BD inpatients or outpatients. The SUDs with the highest prevalence in BD were alcohol use (42%) followed by cannabis use (20%) and other illicit drug use (17%). Meta-analysis showed males had higher lifetime risks of SUDs compared to females. BD and comorbid SUDS were associated with earlier age of onset and slightly more hospitalisations than non-users. LIMITATIONS: The results do not take into account the possibility that individuals may have more than one comorbid disorder, such as having more than one SUD, anxiety disorder, or other combination. Some of the meta-analyses were based on relatively few studies with high rates of heterogeneity. Most included studies were cross-sectional and therefore causality cannot be inferred. CONCLUSIONS: This systematic review shows comorbidity between SUDs and bipolar illness is highly prevalent in hospital and community-based samples. The prevalence of SUDs was similar in patients with bipolar I and bipolar II disorders. This study adds to the literature demonstrating that SUDs are common in BD and reinforces the need to provide better interventions and properly conducted treatment trials to reduce the burden conferred by comorbid SUD and BD.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | 2023 | 37626487 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Clinical Practice Guideline: Assessment and Treatment of Adolescents and Young Adults With Substance Use Disorders and Problematic Substance Use (Excluding Tobacco). | Rockhill CM et al. | — | 2026 | → |
| Incidence and characteristics of bipolar disorder in middle-aged adults: a prospective population-based study. | Lavigne B et al. | — | 2026 | → |
| Neural signatures of bipolar disorder subtypes: A comprehensive systematic review of neuroimaging studies. | Miola A et al. | — | 2026 | → |
| Prevalence and clinical correlates of cocaine use disorder among patients diagnosed with bipolar disorder: A systematic review, meta-analysis, and meta-regression. | de Aguiar KR et al. | — | 2026 | → |
| Adolescent cannabis use and onset of bipolar disorder: gaining causal clarity by viewing the evidence through the Bradford Hill lens. | Bartoli F et al. | — | 2025 | → |
| Alcohol and substance use differentially impact suicidal ideation in a longitudinal cohort of bipolar disorder. | Smith JL et al. | — | 2025 | → |
| A Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability. | Romm KL et al. | — | 2025 | → |
| A review of the 257 meta-analyses of the differences between females and males in prevalence and risk, protective factors, and treatment outcomes for mental disorder. | Kayrouz R et al. | — | 2025 | → |
| Bipolar disorder. | Singh B et al. | — | 2025 | → |
| Bipolar disorder comorbidity in breast cancer: impact of genetic risk and lifestyle characteristic on breast cancer outcomes. | Ercis M et al. | — | 2025 | → |
| Bipolar Disorder Hospitalizations and Substance Use Disorders: A Nationwide Retrospective Study From 2008 To 2015. | Valente L et al. | — | 2025 | → |
| Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders. | Miskowiak KW et al. | — | 2025 | → |
| Cannabis and tobacco use in bipolar disorder: Associations with early onset, psychotic symptoms, and relapse risk (2015-2019). | Olivier L et al. | — | 2025 | → |
| Comprehensive care processes for substance use disorders in adult mental health services: A systematic review. | Reilly J et al. | — | 2025 | → |
| Comprehensive Review on Association of Bipolar Disorder and Substance Abuse: Dual Diagnosis and Treatment Approaches. | Bonner-Reid FT et al. | — | 2025 | → |
| Co-Occurring Bipolar and Substance Use Disorders: A Review of Impacts, Biopsychosocial Mechanisms, Assessment, and Treatment. | Sperry SH et al. | — | 2025 | → |
| Exploration of Genetic Liability to Insomnia and Substance Use Disorders in Patients With Bipolar Disorder. | Melhuish Beaupre LM et al. | — | 2025 | → |
| Exploring the temporal relationship between mood, alcohol- and nicotine use in bipolar disorder using time-series analyses. | Glastad SH et al. | — | 2025 | → |
| Fecal incontinence in hospitalized bipolar disorder patients: prevalence, gender disparities, and associations with demographic and pharmacological factors. | Ashrafi S et al. | — | 2025 | → |
| High-dose buprenorphine inductions in hospital settings. | Wu SA et al. | — | 2025 | → |
| Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments. | De Filippis S et al. | — | 2025 | → |
| Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)-A Review. | Chmiel J et al. | — | 2025 | → |
| Nucleus accumbens functional connectivity changes underlying alcohol expectancies in bipolar disorder and prospective alcohol outcomes: a within-subject randomized placebo-controlled alcohol administration fMRI study. | Lippard ETC et al. | — | 2025 | → |
| Potential causal association between the oral microbiome and bipolar disorder. | Li J et al. | — | 2025 | → |
| Provider Perspectives on Medication for AUD in Mental Health and Substance Use Disorder Clinics. | Kacmarek CN et al. | — | 2025 | → |
| Psychosocial interventions for people with comorbid substance use disorders in people with severe mental health conditions in low- and middle-income countries: scoping review. | Mihretu A et al. | — | 2025 | → |
| Substance use disorders in outpatients with bipolar disorder and pain complaints. | Chabert J et al. | — | 2025 | → |
| The NNDC Road Map for Depression Care and Focused Areas of Research. | — | — | 2025 | → |
| Towards a neurodevelopmental model of bipolar disorder: a critical review of trait- and state-related functional neuroimaging in adolescents and young adults. | Colic L et al. | — | 2025 | → |
| Transitions in mental health care utilisation at GHU Paris between 2019 and 2024: A post-pandemic perspective. | Perozziello A et al. | — | 2025 | → |
| Characterization of Bipolar Disorder I and II: Clinical Features, Comorbidities, and Pharmacological Pattern. | Aguglia A et al. | — | 2024 | → |
| Embitterment in Vietnam War Veterans Predicted by Symptoms of Posttraumatic Stress Disorder. | Lee SH et al. | — | 2024 | → |
| Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals. | Kools N et al. | — | 2024 | → |
| Female Patients Show a Larger Reduction in Suicidal Ideation in Inpatient Addiction Treatment Than Male Patients: Results of a Single-Center Observational Study. | Grote V et al. | — | 2024 | → |
| Genetic liability to insomnia and substance use disorders in patients with bipolar disorder | Melhuish Beaupre LM et al. | — | 2024 | — |
| Lifetime prevalence of psychiatric comorbidities in patients with bipolar disorder: A systematic review and meta-analysis. | Léda-Rêgo G et al. | — | 2024 | → |
| Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention. | McGuirt AF et al. | — | 2024 | → |
| Prediction of medical admissions after psychiatric inpatient hospitalization in bipolar disorder: a retrospective cohort study. | Miola A et al. | — | 2024 | → |
| Referral to hepatology is lower in patients with excessive alcohol use who have mental health disorders despite a high fibrosis-4 index. | Houston K et al. | — | 2024 | → |
| Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial. | Aaronson ST et al. | — | 2024 | → |
| The path from mood symptoms to substance use: A longitudinal examination in individuals with and at risk for bipolar spectrum disorders. | Smith LT et al. | — | 2024 | → |
| Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder. | Mellick WH et al. | — | 2023 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Bipolar affective disorder in India: A multi-site population-based cross-sectional study. | Vajawat B et al. | — | 2023 | → |
| Caring for youth with co-occurring substance use and severe psychiatric disorders: diagnostic challenges and clinical implications. | Keramatian K et al. | — | 2023 | → |
| Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses. | Possidente C et al. | — | 2023 | → |
| Incidence of and risk factors for alcohol dependence in bipolar disorder: A population-based cohort and nested case-control study. | Hsu HE et al. | — | 2023 | → |
| Nicotine use and non-pathological alcohol use and their relationship to affective symptoms and sleep disturbances in bipolar disorder. | Glastad SH et al. | — | 2023 | → |
| Subjective response to alcohol in young adults with bipolar disorder and recent alcohol use: a within-subject randomized placebo-controlled alcohol administration study. | Lippard ETC et al. | — | 2023 | → |
| Substance use outcomes among individuals with severe mental illnesses receiving assertive community treatment: A systematic review. | Abufarsakh B et al. | — | 2023 | → |
| The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. | Keramatian K et al. | — | 2023 | → |
| The experience of mood disorder and substance use: An integrative review. | Crowe M et al. | — | 2023 | → |
| The mediating role of alexithymia in the relationship between affective temperament and craving: Cross-sectional study conducted in a sample of bipolar and alcohol use disorder patients. | Vecchiotti R et al. | — | 2023 | → |
| The Modulated Role of <i>Toxoplasma gondii</i> on Eosinophils in Psychiatric Disorders after Cannabis Cessation. | Romeo B et al. | — | 2023 | → |
| Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use. | Johnstad PG | — | 2023 | → |
| Association between polarity of first episode and solar insolation in bipolar I disorder. | Bauer M et al. | — | 2022 | → |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | — | 2022 | → |
| Bipolar Disorder and Polysubstance Use Disorder: Sociodemographic and Clinical Correlates. | Aguglia A et al. | — | 2022 | → |
| Clinical and demographic factors associated with delayed diagnosis of bipolar disorder: Data from Health Outcomes and Patient Evaluations in Bipolar Disorder (HOPE-BD) study. | Keramatian K et al. | — | 2022 | → |
| Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. | Saha S et al. | — | 2022 | → |
| Developing "MinDag" - an app to capture symptom variation and illness mechanisms in bipolar disorder. | Bjella TD et al. | — | 2022 | → |
| Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis. | Bouchard M et al. | — | 2022 | → |
| Eating Habits and Eating Disorder Associated Behavior in Bipolar Disorder. | Hirte TS et al. | — | 2022 | → |
| Eosinophils to Lymphocytes Ratio (ELR) as a Potential Inflammatory Biomarker in Patients with Dual Diagnosis of Bipolar and Alcohol Use Disorders: A Retrospective Cohort Study. | Dirani E et al. | — | 2022 | → |
| Genetic overlap between mood instability and alcohol-related phenotypes suggests shared biological underpinnings. | Icick R et al. | — | 2022 | → |
| Influence of childhood maltreatment on prevalence, onset, and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders. | Grillault Laroche D et al. | — | 2022 | → |
| Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder. | Oliva V et al. | — | 2022 | → |
| Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment. | López-Toro E et al. | — | 2022 | → |
| Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study. | Icick R et al. | — | 2022 | → |
| The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview. | Bartoli F et al. | — | 2022 | → |
| The impact of substance use disorder comorbidity on cognition of individuals with bipolar disorder: A systematic review. | Gogia M et al. | — | 2022 | → |
| Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis. | Jain R et al. | — | 2022 | → |
| Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review. | Carbone EA et al. | — | 2021 | → |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. | Kozak K et al. | — | 2021 | → |
| Bipolar disorder and cannabis use: A bidirectional two-sample Mendelian randomization study. | Jefsen OH et al. | — | 2021 | → |
| Bipolar Disorder and Comorbid Use of Illicit Substances. | Preuss UW et al. | — | 2021 | → |
| Clinical characteristics and impacts of HIV infection in people with bipolar disorders. | Yalin N et al. | — | 2021 | → |
| Cognition and Cortical Thickness in Heavy Cannabis Users. | Wittemann M et al. | — | 2021 | → |
| Comorbid Bipolar and Alcohol Use Disorder-A Therapeutic Challenge. | Grunze H et al. | — | 2021 | → |
| Effects of polygenic risk for suicide attempt and risky behavior on brain structure in young people with familial risk of bipolar disorder. | Overs BJ et al. | — | 2021 | → |
| Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. | Crowe M et al. | — | 2021 | → |
| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. | Mullins N et al. | — | 2021 | → |
| Manic-Depressive Cycles in Bipolar Disorder: Clinical and Treatment Implications. | Teobaldi E et al. | — | 2021 | → |
| Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. | Oliva F et al. | — | 2021 | → |
| Prevalence of Substance Use among Psychotic Patients and Determining Its Strongest Predictor. | Mousavi SB et al. | — | 2021 | → |
| Reaction Time and Visual Memory in Connection to Alcohol Use in Persons with Bipolar Disorder. | Mazumder AH et al. | — | 2021 | → |
| Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System. | Grunze H et al. | — | 2021 | → |
| Social cognition in first-degree relatives of bipolar disorder: Theory of Mind and nonverbal sensitivity. | Espinós U et al. | — | 2021 | → |
| Substance Misuse Trajectories and Risk of Relapse in the Early Course of Bipolar Disorder. | Lagerberg TV et al. | — | 2021 | → |
| Access to care barriers for patients with Bipolar disorder in the United States. | Crusey A et al. | — | 2020 | → |
| Association Between Bipolar Disorder and Low Bone Mass: A Cross-Sectional Study With Newly Diagnosed, Drug-Naïve Patients. | Li S et al. | — | 2020 | → |
| Care planning and nonpharmacological interventions in a metropolitan inpatient dual diagnosis service: A retrospective exploratory study. | MacLeay E et al. | — | 2020 | → |
| Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders. | Li C et al. | — | 2020 | → |
| From apathy to addiction: Insights from neurology and psychiatry. | Kirschner M et al. | — | 2020 | → |
| Initial and relapse prodromes in adult patients with episodes of bipolar disorder: A systematic review. | Andrade-González N et al. | — | 2020 | → |
| Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: Findings from the UK Bipolar Disorder Research Network. | Gordon-Smith K et al. | — | 2020 | → |
| Prevalence and clinical correlates of substance use amongst acute psychiatric inpatients in Gauteng, South Africa. | Anic A et al. | — | 2020 | → |
| Prevalence of childhood trauma measured by the short form of the Childhood Trauma Questionnaire in people with substance use disorder: A meta-analysis. | Zhang S et al. | — | 2020 | → |
| Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. | Hunt GE et al. | — | 2020 | → |
| Psychiatric comorbidities in bipolar disorders: An examination of the prevalence and chronology of onset according to sex and bipolar subtype. | Loftus J et al. | — | 2020 | → |
| Remission and recurrence in bipolar disorder: The data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study. | Pinto JV et al. | — | 2020 | → |
| Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. | Velosa J et al. | — | 2020 | → |
| The Factor Structure of the Mood Disorder Questionnaire in Tunisian Patients. | Ouali U et al. | — | 2020 | → |
| The impact of substance use disorder on the mental health among COVID-19 patients: A protocol for systematic review and meta-analysis. | Kim YJ et al. | — | 2020 | → |
| The influence of the working alliance on the treatment and outcomes of patients with bipolar disorder: A systematic review. | Andrade-González N et al. | — | 2020 | → |
| The relationship between hopelessness and risk factors for early mortality in people with a lived experience of a serious mental illness. | Fortuna KL et al. | — | 2020 | → |
| Association between solar insolation and a history of suicide attempts in bipolar I disorder. | Bauer M et al. | — | 2019 | → |
| Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis. | Bartoli F et al. | — | 2019 | → |
| Diagnostic Stability in Bipolar Disorder: A Narrative Review. | Cegla-Schvartzman FB et al. | — | 2019 | → |
| High Frequency of Bipolar Disorder Comorbidity in Medical Inpatients. | Ghanbari Jolfaei A et al. | — | 2019 | → |
| Identification and management of alcohol use and illicit substance use in outpatient psychiatric clinics in Sweden: a national survey of clinic directors and staff. | Sundström C et al. | — | 2019 | → |
| Medical and Psychiatric Comorbidities in Bipolar Disorder: Insights from National Inpatient Population-based Study. | Hossain S et al. | — | 2019 | → |
| Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA. | Jia X et al. | — | 2019 | → |
| Psychiatric comorbidities in alcohol use disorder. | Castillo-Carniglia A et al. | — | 2019 | → |
| Psychosocial interventions for people with both severe mental illness and substance misuse. | Hunt GE et al. | — | 2019 | → |
| The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression. | Pinto JV et al. | — | 2019 | → |
| Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder. | Icick R et al. | — | 2019 | → |
| Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review. | Kaufman KR et al. | — | 2018 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Yatham LN et al. | — | 2018 | → |
| Cannabis Use and Hypomania in Young People: A Prospective Analysis. | Marwaha S et al. | — | 2018 | → |
| Clinical risk factors for the development of tardive dyskinesia. | Solmi M et al. | — | 2018 | → |
| Do you let me symptomatize? The potential role of cultural values in cross-national variability of mental disorders' prevalence. | Kapitány-Fövény M et al. | — | 2018 | → |
| Genome-wide QTL analysis for anxiety trait in bipolar disorder type I. | Contreras J et al. | — | 2018 | → |
| No differences in manic-like behaviors between voluntary ethanol and water drinking in Lateral Hypothalamic Kindled (LHK) alcohol preferring rats. | Gawad NA et al. | — | 2018 | → |
| Partners in Recovery program evaluation: changes in unmet needs and recovery. | Hancock N et al. | — | 2018 | → |
| Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis. | Hunt GE et al. | — | 2018 | → |
| [Psychiatric comorbidities of Alcohol dependence]. | Dervaux A et al. | — | 2018 | → |
| Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? | Macfarlane A et al. | — | 2018 | → |
| Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. | Gold AK et al. | — | 2018 | → |
| Commentary on Ostergaard et al. (2017): Evidence of an association between cannabis use and suicide in subjects with bipolar disorder. | Bartoli F | — | 2017 | → |
| Increased risk of chronic obstructive pulmonary disease in patients with bipolar disorder: A population-based study. | Hsu JH et al. | — | 2017 | → |
| Methoxphenidine Use Disorder: First Case Notified to the French Addictovigilance Network. | Champeau W et al. | — | 2017 | → |
| Overview of Substance Use and Mental Health Among the "Baby Boomers" Generation. | Cleary M et al. | — | 2017 | → |
| Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. | Zhu H et al. | — | 2017 | → |
| Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk? | Hulvershorn LA et al. | — | 2017 | → |
| Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | — | 2016 | → |